Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$0.69 - $1.47 $239,222 - $509,649
-346,700 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$0.96 - $2.04 $92,736 - $197,064
96,600 Added 38.62%
346,700 $492,000
Q3 2018

Nov 14, 2018

BUY
$1.54 - $2.38 $154,154 - $238,238
100,100 Added 66.73%
250,100 $538,000
Q2 2018

Aug 14, 2018

BUY
$1.04 - $3.29 $156,000 - $493,500
150,000 New
150,000 $293,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.